tiziana-logo.png
Tiziana Announces Positive Data on Intranasal Anti-CD3 Monoclonal Antibody in Intracerebral Hemorrhage
04 avr. 2023 07h00 HE | Tiziana Life Sciences Ltd.
Tiziana planning to advance foralumab, the only fully human anti-CD3 monoclonal antibody, into human testing for hemorrhagic strokeData shows behavioral outcomes improvement at one month in model of...
GMILogo_Vertical-Gradient.png
Stroke Management Market to hit USD 59 Billion by 2032, says Global Market Insights Inc.
22 nov. 2022 03h10 HE | Global Market Insights Inc.
Selbyville, Delaware, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The stroke management market value is projected to reach USD 59 billion by 2032, according to a new research report by Global Market...
gmi logo.jpg
Stroke management Market revenue to cross USD 48.5 Bn by 2027: Global Market Insights Inc.
15 sept. 2021 04h30 HE | Global Market Insights, Inc
Selbyville, Delaware, Sept. 15, 2021 (GLOBE NEWSWIRE) -- According to latest report “Stroke management Market by Type (Ischemic, Hemorrhagic, Transient Ischemic Attack {TIA}), Product (Diagnostic...
gmi 2018.png
Stroke Management Market revenue to hit $44.5 billion by 2025: Global Market Insights, Inc.
01 juil. 2019 05h30 HE | Global Market Insights, Inc
Selbyville, Delaware, July 01, 2019 (GLOBE NEWSWIRE) -- North America stroke management market accounted for more than 33.5% revenue share in 2018 and is projected to witness momentous growth over...